D. Kumar

In vivo gene therapy with a cationic polymer markedly enhances the antitumor activity of antiangiogenic genes.

S. Stass, A. J. Mixson, Q. Chen, 1998, Molecular genetics and metabolism.

Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice.

S. Stass, A. J. Mixson, Q. Chen, 1999, Cancer research.

Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer

D. Kumar, Y. Dey, U. Mukherjee, 2022, Frontiers in Chemistry.

Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic γδ T cell lymphoma

S. Stass, D. Kumar, E. Jaffe, 1997, Leukemia.

Primary hepatic low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) associated with primary biliary cirrhosis.

L. Medeiros, L. Abruzzo, Dhruv Kumar, 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Gene therapy with p53 and a fragment of thrombospondin I inhibits human breast cancer in vivo.

S. Stass, A. J. Mixson, M. Xu, 1998, Molecular genetics and metabolism.

Classic adamantinoma in a 3-year-old

A. Levine, H. Dorfman, D. Kumar, 1998, Skeletal Radiology.

Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity.

S. Stass, A. J. Mixson, M. Xu, 1997, Human gene therapy.